Aduro Biotech Bolsters Intellectual Property Position in STING Field with Two New Patents

Source 12 August 2017 Biotech

Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced that the United States Patent and Trademark Office has issued two patents to Aduro related to the activation of the STING (Stimulator of Interferon Genes) Pathway.

Eyeglass Sensor Allows for Capturing Eye Blinks for Typing and Controlling External Devices

Source 12 August 2017 Biotech

A team of researchers from Chongqing University and the National Center for Nanoscience and Technology, both in China, has developed a sensor that is able to translate eye muscle movement into electrical signals that can be used to type or control an external device.

Nokia, China's Xiaomi Sign Patent Deal

Source 5 July 2017 General

Telecoms network equipment maker Nokia and Chinese smartphone maker Xiaomi Technology have signed a patent licensing agreement. The agreement includes a cross license to each company's cellular standard patents.

Celltrion, Samsung Bioepis Emerge Strong in Biosimilars Market

Source 5 July 2017 General

South Korea’s Celltrion and Samsung Bioepis are strengthening their foothold in the fast-forming market of biosimilars — cheaper, near-replicas of live cell-based biologic drugs whose patents have expired.

SCOTUS Narrows Forum-Shopping in Big Pharma Action

Source 22-June-2017 Biotech

For the third time this spring, business advocates succeeded in persuading the U.S. Supreme Court to limit forum-shopping by tightening jurisdictional rules that determine where corporate defendants can be sued. In Bristol-Myers Squibb v. Superior Court of California, the court sided with the pharmaceutical company in its battle against a class action brought in California by injured users of Plavix, a blood-thinning drug, even though many of the plaintiffs had little or no connection to the

China will Grant UC CRISPR Patent

Source 22-June-2017 Biotech

China’s State Intellectual Property Office, or SIPO, announced that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology. China’s decision comes amidst a long battle between the UC and the Broad Institute over intellectual property rights for the CRISPR technology.

Patent Granted for Tracking of Aerial Targets Utilizing Video

Source 13 June 2017 Hi-Tech

As the commercial drone market expands at an accelerating rate, so does the risk of malicious use of these devices and the need to successfully detect and take counter measures. This is the focus of the most recent PureTech Systems patent approval.

Microsoft Patent Shows Foldable Windows Phone with Three Modes

Source 13 June 2017 Hi-Tech

The Windows phone in the patent has a folding screen that would allow it to be used like a tablet, and comes with a mysterious 360-degree mode. While many have discussed the possibility of Windows 10 Mobile being killed off, Microsoft has always denied this. The company has continued to support the platform. Recent events have also supported this claim, including hints of a return to making mobile hardware. A Windows patent shows us how Microsoft envisions the smartphone of the future.

LegoChem Biosciences Receives US Patent for Its Own Proprietary ADC Platform Technology ConjuAll

Source 17 April 2017 Biotech

LegoChem Biosciences (“LCB”), a biopharmaceutical company focusing on the research & development of ADCs, based in Daejeon South Korea, announced today that the Company was awarded U.S. Patent No. 14517616, entitled “ANTIBODY-ACTIVE AGENT CONJUGATES AND METHODS OF USE.”

China Provisionally Grants Trump 38 Trademarks – including for Escort Service

Source 17 April 2017 General

Ethics lawyers raise alarm over constitutional violation if president given special treatment in quickly securing 38 new trademarks to develop potential businesses. China has granted preliminary approval for 38 new Trump trademarks, paving the way for Donald Trump and his family to potentially develop a host of branded businesses from hotels to insurance to bodyguard and escort services.

Genprex Reports New Pre-Clinical Data Showing Strong Anti-Tumor Effect Of TUSC2 in Combination with PD-1 Checkpoint Blockade in Lung Cancer

Source 4 April 2017 Biotech

Genprex, Inc. announced new pre-clinical data which reveal that TUSC2 (formerly known as FUS1, the active anti-cancer agent in OncoprexTM) in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlated with prolonged survival in mice.

BioDelivery Sciences gets Expanded US Patent Protection on Belbuca, Bunavail & Onsolis

Source 4 April 2017 Biotech

BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company, announced that two important new patents were granted extending patent protection around all three of its FDA approved products, Belbuca (buprenorphine) buccal film, Bunavail (buprenorphine and naloxone) buccal film, and Onsolis (fentanyl buccal soluble film), further strengthening BDSI's overall intellectual property position.

Cleveland HeartLab LLC Adds New Patent To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Powerful Biomarker For Inflammation And Its Role In Major Cardiac Events

Source 23 February 2017 General

Cleveland HeartLab Inc. announces that a new patent U.S. Patent No. 9,575,065 for Myeloperoxidase (MPO) testing has been issued.

Soligenix (SNGX) Receives European Patent for Formulation of Synthetic Hypericin to Treat Psoriasis

Source 23 February 2017 General

Soligenix, announces that its proprietary formulation of synthetic hypericin has been granted a European patent for the treatment of psoriasis. Synthetic hypericin, the active ingredient in SGX301, completed a Phase 2 clinical study demonstrating significant improvement in both Cutaneous T-cell lymphoma (CTCL) and psoriasis.

Emmaus Life Sciences Receives Notice Of Allowance For Japanese Patent For Use Of L-Glutamine In Treatment Of Diabetes

Source 10 February 2017 General

Emmaus announces the issuance of patent application number 2014-542296, by the Japanese Patent Office for the use of its lead investigative product, pharmaceutical grade L-glutamine (PGLG), for the treatment of diabetes.

Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR

Source 10 February 2017 General

Supernus Pharmaceuticals, announces the issuance of an eighth patent (number 9,555,004) by the USPTO covering Trokendi XR, its novel once-daily extended-release topiramate product.

GPS/Navigation Patents Available from ICAP Patent Brokerage

Source 2 February 2017 February

ICAP Patent Brokerage firm announces for sale of computerized navigation, routing, and location data patents.

Disney Patents Responsive Theme Park Ride Technology

Source 2 February 2017 General

Disney has filed a patent for a responsive theme park ride system that can read and interpret a guest’s emotional state and optimize the ride experience to suit.

LG Patents Foldable Phone-Tablet Hybrid

Source 19 January 2017 General

A new patent has been filed by LG for a foldable phone that holds on to the user hats and folds on the vertical side.

Mithra Pharmaceuticals Release US Patent Allowance for the use of Estetrol as Emergency Contraceptive

Source 19 January 2017 General

Mithra Pharmaceuticals announced that the USPTO has issued a Notice of Allowance for U.S. Application 14/238,310, a patent that covers the use of Estetrol (E4) as an emergency contraceptive.

Knopp Biosciences Receives Key Patent Directed to Treatment for Hypereosinophilic Syndromes, Asthma, and other Eosinophilic Diseases

Source 7 January 2017 General

Knopp Biosciences LLC has received United States Patent 9,468,630 entitled “Compositions and Methods for Treating Conditions Related to Increased Eosinophils.”

Verseon (VSN.L) Granted U.S. Patents Covering Its Novel Serine Protease Inhibitors

Source 7 January 2017 General

The United States Patent and Trademark Office has granted Verseon, US Patents 9,533,967 and 9,533,970, which cover various aspects of multiple families of compounds that were designed by the Company for its drug programs.

IntelliPharmaCeutics Announces Issuance of U.S. & Canadian Patents Covering Aspects of Its PODRAS Overdose Technology

Source 30 December 16 General

Intellipharmaceutics International Inc. announces that the U.S. Patent 9,522,119 and Canadian Patent 2,910,865 were issued by the USPTO and the CIPO in respect of “Compositions and Methods for Reducing Overdose”.

Nokia sues Apple over Infringement of several Mobile Patents

Source 29 December 2016 General

Nokia sued Apple saying the iPhone maker infringed several mobile patents, turning simmering tension between the companies into a bitter public legal battle on multiple fronts.

Nintendo Switch Patents Suggest Possibile Head-Mounted VR Accessory

Source 20 December 2016 General

A published patent application for Nintendo’s upcoming Switch console describes plans for a potential head-mounted display accessory that holds the system's tablet-style screen in virtual reality-style housing.

Regen BioPharma Files Utility Patent Application on NR2F6-Silenced CAR-T Cell for Solid Tumors

Source 20 December 2016 General

Regen BioPharma Inc. announces that the filing of a provisional/nonprovisional utility patent application with the USPTO covers NR2F6-silenced CAR T cells.

Egalet Announces Issuance of New Patent For Egalet-002 and Guardian Technology

Source 9 December 2016 General

Egalet Corporation announces that the USPTO has issued patent number 9,498,446 covering Egalet's proprietary Guardian Technology abuse-deterrent products which contain a matrix and an exterior shell including Phase 3 product candidate, Egalet002.

Shelfbucks Acquires Portfolio of Patents Covering Technology for In-Store POP Display Execution, Compliance, Performance Measurement

Source 9 December 2016 General

Shelfbucks Inc., the number one in-store retail merchandising optimization platform, announced it has acquired 24 granted patents that cover technologies used to measure execution, compliance and performance of in-store merchandising displays.

Tivo and Netflix Sign IP Deal

Source 2 December 2016 General

TiVo has signed an intellectual property and product agreement with Netflix following a five-year patent infringement lawsuit.

Nevro Files Lawsuit For Patent Infringement Against Boston Scientific (BSX) In The U.S.

Source 2 December 2016 General

Nevro Corp. announces that it has filed a lawsuit for patent infringement against Boston Scientific.

Suven bags 2 patents in China and Mexico

Source 25 November 2016 General

A Suven Life Sciences has secured two patents, one each from China and Mexico -- for its new chemical entities (NCEs) used in the treatment of neurodegenerative diseases.

Apple Patents Foldable iPhone with Flexible Display that can Clip onto Clothing

Source 25 November 2016 General

A patent Application published by Apple reveals that the company has been actively investigating a hinged iPhone format, with designs calling for a flexible metal-backed OLED display capable of being folded in half.

Apple Patents Health-Centric Technology For AirPods

Source 18 November 2016 General

Apple has a new patented invention, and it is an advanced device that would be incorporated into a set of earbuds or headsets and the device is capable of collecting important data like body temperature and heart rate, among others.

Absorption Systems Receives U.S. Patent For IDAS2, A Groundbreaking Test System For Fundamental Drug Properties

Source 18 November 2016 General

Absorption Systems, announces the issuance of a U.S. patent for its unique In Vitro Dissolution Absorption System (IDAS2) technology, which enables the simultaneous evaluation of drug dissolution and absorption in various dosage forms, including tablets, capsules, and pre-formulations.

Intec Pharma Granted Chinese Patent For Accordion Pill Carbidopa/Levodopa

Source 11 November 2016 Science

Intec Pharma Ltd., announces that the State Intellectual Property Office of the People’s Republic of China (SIPO) has granted a Chinese patent for an Accordion Pill containing certain drugs, including the combination of Carbidopa and Levodopa.

BrainStorm Cell Granted United States Patent For Its Stem Cell Technology

Source 11 November 2016 Science

BrainStorm Cell Therapeutics Inc. announces that it has been granted United States Patent No. 9,474,787 titled "Mesenchymal Stem Cells for the Treatment of CNS Diseases."

Vanda (VNDA) Settles Fanapt Patent Litigation With Taro (TARO)

Source 26 October 2016 General

Vanda Pharmaceuticals Inc. announces that they had entered into a License Agreement (the License Agreement) with Taro Pharmaceuticals U.S.A., Inc. to resolve Vanda's patent litigation against Taro regarding Taro's Abbreviated New Drug Application seeking approval of its generic version of Vanda's Fanapt (iloperidone).

Army patents new blast debris protective harness

Source 20 October 2016 General

Engineers and designers at the Army Natick Soldier Research, Development and Engineering Center have patented a new design for a harness that protects its wearer from blast debris.

Rivada Networks Expands Patent Portfolio With a Range of Technological Advancements

Source 20 October 2016 General

Rivada Networks announcing the award of multiple new patents to the company by the intellectual property authorities in the United States, Mexico and Australia.

Google Bites Back at Patent Infringement Claim

Source 13 October 2016 General

InfoGation had sued HTC, ZTE and Huawei at the US District Court for the Southern District of California, claiming infringement of US patent number 6,292,743 but Google bitten back to infoGation.

Nasdaq Files Patent for Blockchain Transaction Recordation

Source 13 October 2016 General

Nasdaq has filed a patent for a method of using blockchain technology to secure records of exchange transactions.

Argentum Succeeds In Starting Patent Cancellation Trial Against Janssen's ZYTIGA

Source 1 October 2016 General

U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR) against all claims of the sole unexpired patent listed as covering Janssen's ZYTIGA drug in the Food & Drug Administration's Orange Book.

BioInvent (BOVNF) Expands Patent Approvals For Its Lead Clinical Immuno-Oncology Programme In Multiple Myeloma, BI-505

Source 1 October 2016 General

BioInvent International announces that it has been granted additional patent protection in Japan, Russia and China for BI-505.

Previous Post Next Post

@Twitter

@Facebook